Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 135 | 135 | 134 | 9 |
| Accounts receivable | -19 | -14 | -24 | -17 |
| Accounts payable and accrued liabilities | -66 | 33 | N/A | N/A |
| Other Working Capital | 80 | -100 | -17 | -108 |
| Other Operating Activity | -579 | -615 | -670 | -605 |
| Operating Cash Flow | $-449 | $-561 | $-577 | $-721 |
| Cash Flows From Investing Activities | ||||
| Net Acquisitions | 0 | 0 | 0 | 800 |
| Investing Cash Flow | $0 | $0 | $0 | $800 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 0 | 0 | 0 | 4,295 |
| Other Financing Activity | 0 | 0 | 25 | 0 |
| Financing Cash Flow | $0 | $0 | $25 | $4,295 |
| Beginning Cash Position | 3,260 | 3,821 | 4,374 | 0 |
| End Cash Position | 2,812 | 3,260 | 3,821 | 4,374 |
| Net Cash Flow | $-449 | $-561 | $-552 | $4,374 |
| Free Cash Flow | ||||
| Operating Cash Flow | -449 | -561 | -577 | -721 |
| Free Cash Flow | -449 | -561 | -577 | -721 |